Fusion of the EWS-related gene TAF2N to TEC in extraskeletal myxoid chondrosarcoma

Cancer Research

Volumn 59, Issue 20, 1999, Pages 5064-5067

  Sjögren, Helene ^a   Meis Kindblom, Jeanne ^a   Kindblom, Lars Gunnar ^a   Åman, Pierre ^a   Stenman, Göran ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARCINOGENICITY; CHONDROSARCOMA; CYTOGENETICS; FUSION GENE; GENE FUSION; GENE TRANSLOCATION; HUMAN; HUMAN TISSUE; MALE; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; SOFT TISSUE SARCOMA;

AGED; AMINO ACID SEQUENCE; ARTIFICIAL GENE FUSION; BASE SEQUENCE; CHONDROSARCOMA; CHROMOSOME MAPPING; DNA-BINDING PROTEINS; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; RECEPTORS, STEROID; RECEPTORS, THYROID HORMONE; RIBONUCLEOPROTEINS; RNA, MESSENGER; RNA-BINDING PROTEIN EWS; RNA-BINDING PROTEIN FUS; TATA-BINDING PROTEIN ASSOCIATED FACTORS; TRANSCRIPTION FACTORS;

EID: 0345583702     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Enzinger, F. M., and Shiraki, M. Extraskeletal myxoid chondrosarcoma: an analysis of 34 cases. Hum. Pathol., 3: 421-435, 1972.
2. Meis-Kindblom, J. M., Bergh, P., Gunterberg, B., and Kindblom, L-G. Extraskeletal myxoid chondrosarcoma A reappraisal of its morphologic spectrum and prognostic factors based on 117 cases. Am. J. Surg. Pathol., 23: 636-650, 1999.
3. Sciot, R., Dal Cin, P., Fletcher, C., Samson, I., Smith, M., De Vos, R., Van Damme, B., and Van den Berghe, H. t(9;22)(q22-31;q11-12) is a consistent marker of extraskeletal myxoid chondrosarcoma: evaluation of three cases. Mod. Pathol., 8: 765-768, 1995.
4. Stenman, G., Andersson, H., Mandahl, N., Meis-Kindblom, J. M., and Kindblom, L-G. Translocation t(9;22)(q22;q12) is a primary cytogenetic abnormality in extraskeletal myxoid chondrosarcoma. Int. J. Cancer, 62: 398-402, 1995.
5. Labelle, Y., Zucman, J., Stenman, G., Kindblom, L-G., Knight, J., Turc-Carel, C., Dockhorn-Dworniczak, B., Mandahl, N., Desmaze, C., Aurias, A., Delettre, O., and Thomas, G. Oncogenic conversion of a novel orphan nuclear receptor by chromosome translocation. Hum. Mol. Genet., 4: 2219-2226, 1995.
6. Clark, J., Benjamin, H., Gill, S., Sidhar, S., Goodwin, G., Crew, J., Gusterson, B. A., Shipley, J., and Cooper, C. S. Fusion of the EWS gene to CHN, a member of the steroid/thyroid receptor gene superfamily, in a human myxoid chondrosarcoma. Oncogene, 12: 229-235, 1996.
7. Delattre, O., Zucman, J., Plougastel, B., Desmaze, C., Melot, T., Kovar, H., Joubert, J., de Jong, P., Rouleau, G., Aurias, A., and Thomas, G. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature (Lond.), 319: 162-165, 1992.
8. II68, a novel RNA/ssDNA-binding protein with homology to the pro-oncoproteins TLS/FUS and EWS is associated with both TFIID and RNA polymerase II. EMBO J., 15: 5022-5031, 1996.
9. Morohoshi, F., Arai, K., Takahashi, E. I., Tanigami, A., and Ohki, M. Cloning and mapping of a human RBP56 gene encoding a putative RNA binding protein similar to FUS/TLS and EWS proteins. Genomics. 38: 51-57, 1996.
10. Crozat, A., Åman, P., Mandahl, N., and Ron, D. Fusion of CHOP to a novel RNA-bindirig protein in human myxoid liposarcoma. Nature (Lond.), 363: 540-644, 1993.
11. Rabbitts, T. H., Forster, A., Larson, R., and Nathan, P. Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nat. Genet., 4: 175-180, 1993.
12. Åman, P. Fusion genes in solid tumors. Semin. Cancer Oncol., 9: 303-318, 1999.
13. II68 and FUS/TLS genes. Gene (Amst.), 221: 191-198, 1998.
14. Brody, R. I., Ueda, T., Hamelin, A., Jhanwar, S. C., Bridge, J. A., Healey, J. H., Huvos, A. G., Gerald, W. L., and Ladanyi, M. Molecular analysis of the fusion of EWS to an orphan nuclear receptor gene in extraskeletal myxoid chondrosarcoma. Am. J. Pathol., 150. 1049-1058, 1997.
15. Powers, C. A., Mathur, M., Raaka, B. M., Ron, D., and Samuels, H. H. TLS (translocated-in-liposarcoma) is a high-affinity interactor for steroid, thyroid hormone, and retinoid receptors. Mol. Endocrinol., 12: 4-18, 1998.
16. Zinszner, H., Albalat, R., and Ron, D. A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP. Genes Dev., 8: 2513-2526, 1994.
17. Immanuel, D., Zinszner, H., and Ron, D. Association of SARFH (sarcoma-associated RNA-binding fly homolog) with regions of chromatin transcribed by RNA polymerase II. Mol. Cell Biol., 15: 4562-4571, 1995.
18. Panagopoulos, I., Höglund, M., Mertens, F., Mandahl, N., Mitelman, F., and Åman, P. Fusion of the EWS and CHOP genes in myxoid liposarcoma. Oncogene, 12: 489-494, 1996.
19. Labelle, Y., Bussières, J., Courjal, F., and Goldring, M. B. The EWS/TEC fusion protein encoded by the t(9;22) chromosomal translocation in human chondrosarcomas is a highly potent transcriptional activator. Oncogene, 18: 3303-3308, 1999.
20. Åström, A-K., Voz, M. L., Kas, K., Röijer, E., Wedell, B., Mandahl, N., Van de Ven, W., Mark, J., and Stenman, G. Conserved mechanism of PLAG1 activation in salivary gland tumors with and without chromosome 8q12 abnormalities: identification of SII as a new fusion partner gene. Cancer Res., 59: 918-923, 1999.